Earnings Call · Q1 FY2023·2025-09-29

Q1 23EPS +25.81%·Rev n/aQ4 22EPS -53.57%·Rev n/aQ3 22EPS +20.59%·Rev n/aQ2 22EPS +37.04%·Rev n/a⚠ consensus missing

MoonLake Immunotherapeutics MLTX

Matthias Bodenstedt — Chief Financial Officer

Jorge da Silva — Co-Founder and Chief Executive Officer

Kristian Reich — Co-Founder and Chief Scientific Officer

Alexa Kimball — Professor, external expert

+0.2%1d on move date+0.7% vs SPY3d−2.7%5d+0.1%

Research tier

Behavioral profile computed for 4 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more MLTX calls or request research access.

More MLTX calls Browse calls Request research access